General
OmniSYS Appoints Ann Howard as Executive Vice President, Product Management
Ann will lead the company’s efforts to develop products that support pharmacists and pharmacies in their evolving role as healthcare
April 11, 2022
For media inquiries, please contact ann_baty@omnisys.com.
Ann will lead the company’s efforts to develop products that support pharmacists and pharmacies in their evolving role as healthcare
Pharmacy Times recap of the current status of the test to treat initiative, featuring OmniSYS CIO David Pope, PharmD, CDE. Despite AMA pushback, pharmacy is ready for test and treat.
The Drug Topics editorial board, including OmniSYS CIO David Pope, PharmD, CDE responds to the AMA’s recent negative statement regarding the test to treat initiative outlined by the Biden Administration.
Pharmacy Times interview with OmniSYS CIO David Pope and Christina Madison, The Public Health Pharmacist, discussing the new test to treat plan mentioned in the 2022 State of the Union.
Test to treat in pharmacy: Drug Topics asked OmniSYS chief innovation officer David Pope for his thoughts regarding test to treat after President Biden’s 2022 State of the Union address.
Clinical pharmacy is in demand and sustainable pharmacy technology makes it happen. Pharmacies must make the most of current technology investments, and building upon them for an automated, efficient future.
XIFIN’s acquisition of OmniSYS is the latest evidence that pharmacies are the front door to healthcare. Uniting lab data with pharmacy data is a game-changer, for now and the future.
As clinical pharmacy thrives, the biggest hurdle to continued growth is a lack of data. Our partnership with XIFIN will unite testing and pharmacy data for a powerful knowledge base.
Great news! We’ve enhanced our Medicare Part D Comparison Tool to better support your pharmacy during open enrollment, included free of charge with our clinical services and patient communications solutions.
To combat the growing diabetes epidemic, OmniSYS is partnering with the CDC, NSPA and ADCES and 30 community pharmacies, focusing on delaying or preventing type 2 diabetes through preventative encounters.
DSN sat down with OmniSYS CEO John King to discuss the challenges COVID-19 brought tor the pharmacy industry and how OmniSYS has been able to assist pharmacists with said challenges.
The Drug Store News March 2021 cover story takes a deep dive into the essential role pharmacies are playing in COVD-19 vaccinations, with insights from key players across the industry.
Copyright 2022 Omnisys, LLC. All rights reserved.